AUF1 and HuR: Possible implications of mRNA stability in thyroid function and disorders

Thyroid Research

Volumn 4, Issue SUPPL. 1, 2011, Pages

  Trojanowicz, Bogusz ^a   Dralle, Henning ^a   Hoang Vu, Cuong ^a  

^a MARTIN LUTHER UNIVERSITÄT HALLE WITTENBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 79961185620     PISSN: None     EISSN: 17566614     Source Type: Journal    
DOI: 10.1186/1756-6614-4-S1-S5     Document Type: Review

References (85)

1. An A+U-rich element RNA-binding factor regulates c-myc mRNA stability in vitro. G Brewer, Mol Cell Biol 1991 11 2460 2466 1901943 (Pubitemid 21895624)
2. AUF1 binding affinity to A+U-rich elements correlaates with rapid mRNA degradation. CT DeMaria G Brewer, J Biol Chem 1996 271 12179 12184 10.1074/jbc.271.21.12179 8647811 (Pubitemid 26160876)
3. A conserved family of elav-like genes in vetebrates. PJ Good, Proc Natl Acad Sci U S A 1995 92 4557 4561 10.1073/pnas.92.10.4557 7753842
4. Cloning and characterization of HuR, a ubiquitously expressed Elav-like protein. WJ Ma S Cheng C Campell A Wrignt H Furneaux, J Biol Chem 1996 271 8144 8151 10.1074/jbc.271.14.8144 8626503 (Pubitemid 26108641)
5. Unraveling a cytoplasmic rolr for hnRNPD in the in vivo mRNA destabilization directed by the AU-rich element. P Loflin CYA Chen AN Shyu, Genes Dev 1999 13 1884 1897 10.1101/gad.13.14.1884 10421639 (Pubitemid 29353054)
6. Purification, characterization and cDNA cloning of an AU-rich element RNA-binding protein, AUF1. W Zhang BJ Wagner K Ehrenmann AW Schaefer CT DeMaria D Crater K DeHaven L Long G Brewer, Mol Cell Biol 1993 13 7652 7665 8246982 (Pubitemid 23354290)
7. HuR regulated Cyclin A and cyclin B1 mRNA stability during cell proliferation. W Wang MC Caldwell S Lin H Furneaux M Gorospe, EMBO J 2000 19 10 2340 2350 10.1093/emboj/19.10.2340 10811625 (Pubitemid 30259015)
8. Two separate regions essential for nuclear import of the hnRNP D nucleocytoplasmic shuttling sequence. M Suzuki M Iijima A Nishimura Y Tomozoe D Kamei M Yamada, FEBS J 2005 272 3975 3987 10.1111/j.1742-4658.2005.04820.x 16045768 (Pubitemid 41117229)
9. HNS, a nuclear-cytoplasmic shuttling sequence in HuR. XC Fan JA Steitz, Proc Natl Acad Sci U S A 1998 95 15293 15298 10.1073/pnas.95.26.15293 9860962 (Pubitemid 29018692)
10. FRET-detectable interactions between the ARE binding proteins, HuR and p37AUF1. PS David R Tanveer JD Port, RNA 2007 13 1453 1468 10.1261/rna.501707 17626845 (Pubitemid 47347416)
11. Identification and characterization of proteins that selectively interact with isoforms of the mRNA binding protein AUF1 (hnRNP D). KC Moraes AJ Quaresma K Maehnss J Kobarg, Biol Chem 2003 384 25 37 10.1515/BC.2003.004 12674497 (Pubitemid 36322629)
12. Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. JD Dignam RM Lebovitz RG Roeder, Nucleic Acids Res 1983 11 1475 1489 10.1093/nar/11.5.1475 6828386
13. Molecular identification of I1PP2A, a novel potent heat-stable inhibitor protein of protein phosphatase 2A. M Li A Makkinje Z Damuni, Biochemistry 1996 35 6998 7002 10.1021/bi960581y 8679524
14. The interconversion of protein phosphatase 2A between PP2A1 and PP2A0 during retinoic acid-induced granulocytic differentiation and a modification on the catalytic subunit in S phase of HL-60 cells. T Zhu S Matsuzawa Y Mizuno C Kamibayashi MC Mumby N Andjelkovic BA Hemmings K Onoé K Kikuchi, Arch Biochem Biophys 1997 339 210 217 10.1006/abbi.1996.9835 9056251 (Pubitemid 27199770)
15. Regulation of protein kinase cascades by protein phosphatase 2A. TA Millward S Zolnierowicz BA Hemmings, Trends Biochem Sci 1999 24 186 191 10.1016/S0968-0004(99)01375-4 10322434 (Pubitemid 29348452)
16. HuR uses AUF1 as a cofactor to promote p16INK4 mRNA decay. N Chang J Yi G Guo X Liu Y Shang T Tong Q Cui M Zhan M Gorospe W Wang, Mol Cell Biol 2010 30 3875 3886 10.1128/MCB.00169-10 20498276
17. ARED: human AU-rich element containing mRNA database reveals an unexpectedly diverse functional repertoire of encoded proteins. T Bakheed M Frevel BR Williams W Greer KS Khabar, Nucleic Acids Res 2001 29 246 254 10.1093/nar/29.1.246 11125104 (Pubitemid 32054460)
18. AREsite: a database for the comprehensive investigation of AU-rich elements. AR Gruber J Fallmann F Kratochvill P Kovarik IL Hofacker, Nucleic Acids Res 2011 39 Database issue 66 9 21071424
19. Identification of a target RNA motif for RNA-binding protein HuR. I Lápez de Silanes M Zhan A Lal X Yang M Gorospe, Proc Natl Acad Sci U S A 2004 101 2987 2992 10.1073/pnas.0306453101 14981256 (Pubitemid 38327723)
20. Identification of a signature motif in target mRNAs of RNA-binding protein AUF1. K Mazan-Mamczarz Y Kuwano M Zhan EJ White JL Martindale A Lal M Gorospe, Nucleic Acids Res 2009 37 204 214 10.1093/nar/gkn929 19033365
21. Synchronous and regulated expression of two AU-binding proteins, AUF1 and HuR, throughout murine development. A Gouble D Morello, Oncogene 2000 19 5377 5384 10.1038/sj.onc.1203910 11103939
22. AUF1 and Hu proteins in the developing rat brain: implication in the proliferation and differentiation of neural progenitors. D Hambardzumyan S Sergent-Tanguy R Thinard V Bonnamain M Masip A Fabre H Boudin I Neveu P Naveilhan, J Neurosci Res 2009 87 1296 1309 10.1002/jnr.21957 19115409
23. HuR/methyl-HuR and AUF1 regulate the MAT expressed during liver proliferation, differentiation, and carcinogenesis. M Vázquez-Chantada D Fernández-Ramos N Embade N Martínez-Lopez M Varela-Rey A Woodhoo Z Luka C Wagner PP Anglim RH Finnell J Caballería IA Laird-Offringa M Gorospe SC Lu JM Mato ML Martínez-Chantar, Gastroenterology 2010 138 1943 1953 10.1053/j.gastro.2010.01.032 20102719
24. Auf1/Hnrnpd-deficient mice develop pruritic inflammatory skin disease. Auf1/Hnrnpd-deficient mice develop pruritic inflammatory skin disease. N Sadri RJ Schneider, J Invest Dermatol 2009 129 657 670 10.1038/jid.2008.298 18830269
25. Thyroid abnormalities in dermatitis herpetiformis. Prevalence of clinical thyroid disease and thyroid autoantibodies. MJ Cunningham JJ Zone, Ann Intern Med 1985 102 194 196 3966757 (Pubitemid 15157168)
26. Skin findings in thyroid diseases. S Artantas U Gül A Kiliç S Güler, Eur J Intern Med 2009 20 158 161 10.1016/j.ejim.2007.09.021 19327604
27. Endotoxic shock in AUF1 knockout mice mediated by failure to degrade proinflammatory cytokine mRNAs. JY Lu N Sadri RJ Schneider, Genes Dev 2006 20 3174 3184 10.1101/gad.1467606 17085481 (Pubitemid 44790631)
28. AUF1 is involved in splenic follicular B cell maintenance. N Sadri JY Lu ML Badura RJ Schneider, BMC Immunol 2010 11 1 10.1186/1471-2172-11-1 20064252
29. The RNA-binding protein Elavl1/HuR is essential for placental branching morphogenesis and embryonic development. V Katsanou S Milatos A Yiakouvaki N Sgantzis A Kotsoni M Alexiou V Harokopos V Aidinis M Hemberger DL Kontoyiannis, Mol Cell Biol 2009 29 2762 2776 10.1128/MCB.01393-08 19307312
30. Thyroid hormone decreases the stability and the poly(A) tract length of rat thyrotropin beta-subunit messenger RNA. IM Krane ER Spindel WW Chin, Mol Endocrinol 1991 5 469 475 10.1210/mend-5-4-469 1922079
31. Posttranscriptional regulation of thyrotropin beta-subunit messenger ribonucleic acid by thyroid hormone in murine thyrotrope tumor cells: a conserved mechanism across species. JM Staton PJ Leedman, Endocrinology 1998 139 1093 1100 10.1210/en.139.3.1093 9492042 (Pubitemid 28510127)
32. T3 rapidly modulates TSH mRNA stability and translational rate in the pituitary of hypothyroid rats. F Goulart-Silva PB de Souza MT Nunes, Mol Cell Endocrinol 2011 332 277 282 10.1016/j.mce.2010.11.005 21078364
33. Regulated specific protein binding to a conserved region of the 3'-untranslated region of thyrotropin beta-subunit mRNA. PJ Leedman AR Stein WW Chin, Mol Endocrinol 1995 9 375 387 10.1210/me.9.3.375 7776983
34. Posttranscriptional regulation of rat growth hormone gene expression: increased message stability and nuclear polyadenylation accompany thyroid hormone depletion. D Murphy K Pardy V Seah D Carter, Mol Cell Biol 1992 12 2624 2632 1588960
35. T3 acutely increases GH mRNA translation rate and GH secretion in hypothyroid rats. FG Silva G Giannocco AD Luchessi R Curi MT Nunes, Mol Cell Endocrinol 2010 317 1 7 10.1016/j.mce.2009.12.005 20015464
36. Post-transcriptional downregulation of sarcolipin mRNA by triiodothyronine in the atrial myocardium. S Minamisawa N Uemura Y Sato U Yokoyama T Yamaguchi K Inoue M Nakagome Y Bai H Hori M Shimizu S Mochizuki Y Ishikawa, FEBS Lett 2006 580 2247 2252 10.1016/j.febslet.2006.03.032 16566928
37. Phosphorylation and binding of AUF1 to the 3'-untranslated region of cardiomyocyte SERCA2a mRNA. JL Blum AM Samarel R Mestril, Am J Physiol Heart Circ Physiol 2005 289 2543 2550 10.1152/ajpheart.00545.2005 16113063
38. AUF1 is upregulated by angiotensin II to destabilize cardiac Kv4.3 channel mRNA. C Zhou CZ Vignere ES Levitan, J Mol Cell Cardiol 2008 45 832 838 10.1016/j.yjmcc.2008.08.004 18789946
39. Type 2 iodothyronine deiodinase in rat pituitary tumor cells is inactivated in proteasomes. J Steinsapir J Harney PR Larsen, J Clin Invest 1998 102 1895 1899 10.1172/JCI4672 9835613 (Pubitemid 29001834)
40. Selective proteolysis of human type 2 deiodinase: a novel ubiquitin-proteasomal mediated mechanism for regulation of hormone activation. B Gereben C Goncalves JW Harney PR Larsen AC Bianco, Mol Endocrinol 2000 14 1697 1708 10.1210/me.14.11.1697 11075806
41. Deubiquitination of type 2 iodothyronine deiodinase by von Hippel-Lindau protein-interacting deubiquitinating enzymes regulates thyroid hormone activation. C Curcio-Morelli AM Zavacki M Christofollete B Gereben BC de Freitas JW Harney Z Li G Wu AC Bianco, J Clin Invest 2003 112 189 196 12865408 (Pubitemid 38056355)
42. Ubiquitination-induced conformational change within the deiodinase dimer is a switch regulating enzyme activity. GD Sagar B Gereben I Callebaut JP Mornon A Zeöld WS da Silva C Luongo M Dentice SM Tente BC Freitas JW Harney AM Zavacki AC Bianco, Mol Cell Biol 2007 27 4774 4783 10.1128/MCB.00283-07 17452445 (Pubitemid 47016130)
43. The T3 receptor beta1 isoform regulates UCP1 and D2 deiodinase in rat brown adipocytes. R Martinez de Mena TS Scanlan MJ Obregon, Endocrinology 2010 151 5074 5083 10.1210/en.2010-0533 20719854
44. Neuroserpin is post-transcriptionally regulated by thyroid hormone. C Navarro-Yubero A Cuadrado P Sonderegger A Mũoz, Brain Res Mol Brain Res 2004 123 56 65 15046866 (Pubitemid 38392064)
45. Positive and negative regulation of retinoid X receptor gene expression by thyroid hormone in the rat. Transcriptional and post-transcriptional controls by thyroid hormone. H Mano R Mori T Ozawa K Takeyama Y Yoshizawa R Kojima Y Arao S Masushige S Kato, J Biol Chem 1994 269 1591 1594 8294402 (Pubitemid 24035343)
46. Selenoproteins of the thyroid gland: expression, localization and possible function of glutathione peroxidase 3. C Schmutzler B Mentrup L Schomburg C Hoang-Vu V Herzog J Köhrle, Biol Chem 2007 388 1053 1059 10.1515/BC.2007.122 17937619 (Pubitemid 47584302)
47. Cis and trans acting factors in the regulation of parathyroid hormone (PTH) mRNA stability by calcium and phosphate. T Naveh-Many O Bell J Silver R Kilav, FEBS Lett 2002 529 60 64 10.1016/S0014-5793(02)03259-3 12354614 (Pubitemid 35283913)
48. Noncoding 3' sequences of the transferrin receptor gene are required for mRNA regulation by iron. D Owen LC Kühn, EMBO J 1987 6 1287 1293 3608980
49. Thyroid hormones regulate selenoprotein expression and selenium status in mice. J Mittag T Behrends CS Hoefig B Vennström L Schomburg, PLoS One 2010 5 12931 10.1371/journal.pone.0012931 20877559
50. Identification of AUF1 as a parathyroid hormone mRNA 3'-untranslated region-binding protein that determines parathyroid hormone mRNA stability. A Sela-Brown J Silver G Brewer T Naveh-Many, J Biol Chem 2000 275 7424 7429 10.1074/jbc.275.10.7424 10702317 (Pubitemid 30146298)
51. Selective control of cytosolic glutathione peroxidase and phospholipid hydroperoxide glutathione peroxidase mRNA stability by selenium supply. G Bermano JR Arthur JE Hesketh, FEBS Lett 1996 387 157 160 10.1016/0014-5793(96) 00493-0 8674540 (Pubitemid 26178914)
52. Selenium-dependent pre- and posttranscriptional mechanisms are responsible for sexual dimorphic expression of selenoproteins in murine tissues. C Riese M Michaelis B Mentrup F Götz J Köhrle U Schweizer L Schomburg, Endocrinology 2006 147 5883 5892 10.1210/en.2006-0689 16959840 (Pubitemid 44833505)
53. Posttranscriptional regulation of sodium-iodide symporter mRNA expression in the rat thyroid gland by acute iodide administration. C Serrano-Nascimento J Calil-Silveira MT Nunes, Am J Physiol Cell Physiol 2010 298 893 C899 10.1152/ajpcell.00224.2009 20107044
54. The role of AUF1 in thyroid carcinoma progression. B Trojanowicz L Brodauf C Sekulla K Lorenz R Finke H Dralle C Hoang-Vu, Endocr Relat Cancer 2009 16 857 871 10.1677/ERC-08-0234 19574297
55. Downregulation of microRNAs directs the EMT and invasive potential of anaplastic thyroid carcinomas. J Braun C Hoang-Vu H Dralle S Hüttelmaier, Oncogene 2010 29 4237 4244 10.1038/onc.2010.169 20498632
56. Relationship between RKIP protein expression and clinical staging in thyroid carcinoma. B Trojanowicz T Fu O Gimm C Sekulla R Finke H Dralle C Hoang-Vu, Open Endocrinology Journal 2008 2 16 20 10.2174/1874216500802010016
57. Retinoic acid mediated down-regulation of ENO1/ MBP-1 gene products caused decreased invasiveness of the follicular thyroid carcinoma cell lines. B Trojanowicz A Winkler K Hammje Z Chen C Sekulla D Glanz C Schmutzler B Mentrup S Hombach-Klonisch T Klonisch R Finke J Köhrle H Dralle C Hoang-Vu, J Mol Endocrinol 2009 42 249 260 19060179
58. CD82, and CD63 in thyroid cancer. Z Chen T Mustafa B Trojanowicz M Brauckhoff O Gimm C Schmutzler J Köhrle HJ Holzhausen A Kehlen T Klonisch R Finke H Dralle C Hoang-Vu, Int J Mol Med 2004 14 517 527 15375577
59. Treatment concepts of acute promyelocytic leukemia. E Lengfelder S Saussele A Weisser T Buchner R Hehlmann, Crit Rev Oncol Hematol 2005 56 261 274 10.1016/j.critrevonc.2004.08.009 16236522 (Pubitemid 41565553)
60. Retinoids in chemoprevention and differentiation therapy. LA Hansen CC Sigman F Andreola SA Ross GJ Kelloff LM De Luca, Carcinogenesis 2000 21 1271 1279 10.1093/carcin/21.7.1271 10874003 (Pubitemid 30455984)
61. Clinical impact of retinoids in redifferentiation therapy of advanced thyroid cancer: final results of a pilot study. D Simon C Körber M Krausch J Segering P Groth R Görges F Grünwald HW Müller-Gärtner C Schmutzler J Köhrle HD Röher C Reiners, Eur J Nucl Med Mol Imaging 2002 29 775 782 10.1007/s00259-001-0737-6 12029551
62. 13-cis-retinoic acid re-differentiation therapy and recombinant human thyrotropin-aided radioiodine treatment of non-Functional metastatic thyroid cancer: a single-center, 53-patient phase 2 study. D Handkiewicz-Junak J Roskosz K Hasse-Lazar S Szpak-Ulczok Z Puch A Kukulska T Olczyk A Piela E Paliczka-Cieslik B Jarzab, Thyroid Res 2009 2 8 10.1186/1756-6614-2-8 19646277
63. Effectiveness of retinoic acid treatment for redifferentiation of thyroid cancer in relation to recovery of radioiodine uptake. CA Fernández M Puig-Domingo F Lomẽa M Estorch V Camacho Martí AL Bittini M Marazuela J Santamaría J Castro P Martínez de Icaya I Moraga T Martín A Megía M Porta D Mauricio I Halperin, J Endocrinol Invest 2009 32 228 233 19542739
64. Retinoic acid redifferentiation therapy for thyroid cancer. C Schmutzler J Kohrle, Thyroid 2000 10 393 406 10.1089/thy.2000.10.393 10884186 (Pubitemid 30418744)
65. Human thyroid carcinoma cell lines show different retinoic acid receptor repertoires and retinoid responses. C Schmutzler C Hoang-Vu B Rüger J Kohrle, Eur J Endocrinol 2004 150 547 556 10.1530/eje.0.1500547 15080786 (Pubitemid 38584707)
66. Proteomic approach reveals novel targets for retinoic acid-mediated therapy of thyroid carcinoma. B Trojanowicz C Sekulla K Lorenz J Köhrle R Finke H Dralle C Hoang-Vu, Mol Cell Endocrinol 2010 325 110 117 10.1016/j.mce.2010.05.022 20538039
67. A new player in oncogenesis: AUF1/hnRNPD overexpression leads to tumorigenesis in transgenic mice. A Gouble S Grazide F Meggetto P Mercier G Delsol D Morello, Cancer Res 2002 62 1489 1495 11888925 (Pubitemid 34407812)
68. Differential expres-sion and localization of the mRNA binding proteins, AU-rich element mRNA binding protein (AUF1) and Hu antigen R (HuR), in neoplastic lung tissue. BC Blaxall LD Dwyer-Nield AK Bauer TJ Bohlmeyer AM Malkinson JD Port, Mol Carcinog 2000 28 76 83 10.1002/1098-2744(200006)28: 2<76::AID-MC3>3.0.CO;2-0 10900464 (Pubitemid 30432475)
69. HuR, a key post-transcriptional regulator, and its implication in progression of breast cancer. Z Yuan AJ Sanders L Ye WG Jiang, Histol Histopathol 2010 25 1331 1340 20712017
70. HuR knockdown changes the oncogenic potential of oral cancer cells. W Kakuguchi T Kitamura T Kuroshima M Ishikawa Y Kitagawa Y Totsuka M Shindoh F Higashino, Mol Cancer Res 2010 8 520 528 10.1158/1541-7786.MCR-09-0367 20332213
71. A "liaison dangereuse" between AUF1/hnRNPD and the oncogenic tyrosine kinase NPM-ALK. M Fawal F Armstrong S Ollier H Dupont C Touriol B Monsarrat G Delsol B Payrastre D Morello, Blood 2006 108 2780 2788 10.1182/blood-2006-04-014902 16835382
72. RNA-binding protein hnRNP D modulates internal ribosome entry site-dependent translation of hepatitis C virus RNA. KY Paek CS Kim SM Park JH Kim SK Jang, J Virol 2008 82 12082 12093 10.1128/JVI.01405-08 18842733
73. IGF2BP1 enhances HCV IRES-mediated translation initiation via the 3'UTR. S Weinlich S Hüttelmaier A Schierhorn SE Behrens A Ostareck-Lederer DH Ostareck, RNA 2009 15 1528 1542 10.1261/rna.1578409 19541769
74. Regulation of the hTERT promoter activity by MSH2, the hnRNPs K and D, and GRHL2 in human oral squamous cell carcinoma cells. X Kang W Chen RH Kim MK Kang NH Park, Oncogene 2009 28 565 574 10.1038/onc.2008.404 19015635
75. Down-regulation of cyclin D1 expression by prostaglandin A(2) is mediated by enhanced cyclin D1 mRNA turnover. S Lin W Wang GM Wilson X Yang G Brewer NJ Holbrook M Gorospe, Mol Cell Biol 2000 20 7903 7913 10.1128/MCB.20.21.7903-7913. 2000 11027261
76. Increased interleukin-10 mRNA stability in melanoma cells is associated with decreased levels of A + U-rich element binding factor AUF1. G Brewer S Saccani S Sarkar A Lewis S Pestka, J Interferon Cytokine Res 2003 23 553 564 10.1089/107999003322485053 14585195 (Pubitemid 37323677)
77. AUF1, the regulator of tumor necrosis factor alpha messenger RNA decay, is targeted by autoantibodies of patients with systemic rheumatic diseases. K Skriner W Hueber E Süleymanoglu E Höfler V Krenn J Smolen G Steiner, Arthritis Rheum 2008 58 511 520 10.1002/art.23306 18240226 (Pubitemid 351294885)
78. HuR, a novel target of anti-Hu antibodies, is expressed in non-neural tissues. LB Nabors HM Furneaux PH King, J Neuroimmunol 1998 92 152 159 10.1016/S0165-5728(98)00196-9 9916890 (Pubitemid 29016000)
79. RNA-binding proteins implicated in the hypoxic response. K Masuda K Abdelmohsen M Gorospe, J Cell Mol Med 2009 13 2759 2769 10.1111/j.1582-4934. 2009.00842.x 19583805
80. Essential role of the RNA-binding protein HuR in progenitor cell survival in mice. M Ghosh HL Aguila J Michaud Y Ai MT Wu A Hemmes A Ristimaki C Guo H Furneaux T Hla, J Clin Invest 2009 119 3530 3543 10.1172/JCI38263 19884656
81. Increased stability of the p16 mRNA with replicative senescence. W Wang JL Martindale X Yang FJ Chrest M Gorospe, EMBO Rep 2005 6 158 164 10.1038/sj.embor.7400346 15678155 (Pubitemid 40309413)
82. Hydrogen peroxide induces p16(INK4a) through an AUF1-dependent manner. GE Guo LW Ma B Jiang J Yi TJ Tong WG Wang, J Cell Biochem 2010 109 1000 1005 20069554
83. Reduced nuclear export of HuR mRNA by HuR is linked to the loss of HuR in replicative senescence. J Yi N Chang X Liu G Guo L Xue T Tong M Gorospe W Wang, Nucleic Acids Res 2010 38 1547 1558 10.1093/nar/gkp1114 20007147
84. Involvement of RNA binding proteins AUF1 in mammary gland differentiation. K Nagaoka T Tanaka K Imakawa S Sakai, Exp Cell Res 2007 313 2937 2945 10.1016/j.yexcr.2007.04.017 17512931 (Pubitemid 47126434)
85. Thyroid stem cells and cancer. T Klonisch C Hoang-Vu S Hombach-Klonisch, Thyroid 2009 19 1303 1315 10.1089/thy.2009.1604 20001714